US Stock MarketDetailed Quotes

RGNX Regenxbio

Watchlist
  • 8.570
  • -0.150-1.72%
Trading Dec 13 10:47 ET
424.60MMarket Cap-1.71P/E (TTM)

Regenxbio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.93%-40.55M
3.86%-45.5M
31.47%-55.46M
-5.26%-218.41M
-3.53%-40.76M
2.08%-49.41M
23.36%-47.32M
-44.73%-80.92M
-194.80%-207.49M
-111.53%-39.37M
Net income from continuing operations
3.67%-59.6M
26.47%-52.99M
5.02%-63.33M
6.00%-263.49M
-4.93%-62.89M
18.04%-61.87M
-5.69%-72.06M
13.10%-66.68M
-319.27%-280.32M
-120.38%-59.94M
Operating gains losses
----
----
----
-2,891.14%-2.21M
--0
----
----
----
101.52%79K
--0
Depreciation and amortization
-9.40%3.96M
-8.66%4.05M
0.05%4.18M
34.17%17.32M
5.07%4.34M
23.19%4.37M
67.80%4.44M
61.25%4.18M
34.97%12.91M
58.33%4.13M
Other non cash items
-45.85%450K
-1.42%-715K
188.65%617K
-125.82%-95K
170.37%475K
669.44%831K
-169.25%-705K
-738.55%-696K
-91.56%368K
-386.02%-675K
Change In working capital
1,074.16%6.07M
-139.86%-4.04M
72.45%-8.16M
-177.89%-10.89M
35.61%9.22M
-106.24%-623K
214.33%10.13M
-589.94%-29.61M
-65.25%13.98M
-83.85%6.8M
-Change in receivables
89.15%-710K
-188.77%-6.89M
-3.35%9.18M
-18.39%3.94M
-30.45%3.37M
-230.68%-6.54M
77.73%-2.39M
66.90%9.5M
-65.85%4.82M
-77.99%4.84M
-Change in prepaid assets
-138.46%-981K
772.62%3.57M
157.37%930K
-112.78%-620K
-312.01%-1.96M
79.52%2.55M
-82.19%409K
-871.90%-1.62M
158.83%4.85M
363.25%924K
-Change in payables and accrued expense
82.71%9.23M
-167.88%-5.39M
53.54%-8.62M
95.03%-339K
15.14%5.22M
7.26%5.05M
225.06%7.94M
-90.84%-18.55M
-124.73%-6.83M
-78.03%4.53M
-Change in other current assets
386.29%355K
-1.02%6.61M
66.74%-4.71M
-167.58%-3.2M
439.83%4.41M
-96.83%-124K
224.96%6.68M
-837.19%-14.15M
200.17%4.73M
203.16%816K
-Change in other current liabilities
-25.32%-1.95M
-11.87%-1.94M
-10.38%-4.81M
-221.02%-9.16M
-365.03%-1.52M
-255.96%-1.55M
-550.65%-1.74M
-154.80%-4.35M
-38.80%7.57M
-121.52%-326K
-Change in other working capital
2,150.00%123K
101.03%8K
68.82%-135K
-29.79%-1.51M
92.63%-294K
99.07%-6K
---779K
---433K
-29.59%-1.17M
---3.99M
Cash from discontinued investing activities
Operating cash flow
17.93%-40.55M
3.86%-45.5M
31.47%-55.46M
-5.26%-218.41M
-3.53%-40.76M
2.08%-49.41M
23.36%-47.32M
-44.73%-80.92M
-194.80%-207.49M
-111.53%-39.37M
Investing cash flow
Cash flow from continuing investing activities
30.01%50.26M
-100.49%-268K
-79.11%13.18M
1,700.66%190.94M
27.24%33.97M
-27.12%38.66M
5,208.05%55.22M
169.65%63.09M
97.07%-11.93M
112.34%26.7M
Net PPE purchase and sale
77.35%-326K
81.61%-474K
88.44%-557K
67.58%-9.96M
79.41%-1.13M
71.50%-1.44M
72.10%-2.58M
56.07%-4.82M
63.50%-30.72M
62.57%-5.47M
Net investment purchase and sale
26.16%50.58M
-99.64%206K
-79.77%13.74M
968.92%200.9M
9.11%35.1M
-30.98%40.1M
608.62%57.8M
185.29%67.91M
105.83%18.8M
115.95%32.17M
Cash from discontinued investing activities
Investing cash flow
30.01%50.26M
-100.49%-268K
-79.11%13.18M
1,700.66%190.94M
27.24%33.97M
-27.12%38.66M
5,208.05%55.22M
169.65%63.09M
97.07%-11.93M
112.34%26.7M
Financing cash flow
Cash flow from continuing financing activities
-125.95%-10.86M
-3.09%-9.45M
1,435.90%120.73M
-21.24%-34.97M
-34.10%-11.96M
11.30%-4.81M
-19.47%-9.16M
-32.24%-9.04M
-114.77%-28.84M
-17.12%-8.92M
Net common stock issuance
-95.98%246K
--0
22,543.57%132.01M
284.62%6.7M
--0
446.16%6.12M
--0
-6.27%583K
-99.20%1.74M
--0
Proceeds from stock option exercised by employees
332.61%398K
-74.37%192K
87.69%884K
-45.76%1.52M
386.05%209K
-89.97%92K
-50.30%749K
39.76%471K
-34.50%2.8M
-95.63%43K
Net other financing activities
-4.42%-11.5M
2.76%-9.64M
-20.61%-12.17M
-29.36%-43.19M
-35.79%-12.17M
-47.76%-11.01M
-8.01%-9.91M
-29.49%-10.09M
-22.58%-33.39M
-4.21%-8.96M
Cash from discontinued financing activities
Financing cash flow
-125.95%-10.86M
-3.09%-9.45M
1,435.90%120.73M
-21.24%-34.97M
-34.10%-11.96M
11.30%-4.81M
-19.47%-9.16M
-32.24%-9.04M
-114.77%-28.84M
-17.12%-8.92M
Net cash flow
Beginning cash position
-15.61%59.8M
59.46%115.01M
-63.07%36.55M
-71.49%98.98M
-54.14%55.3M
-42.58%70.86M
-62.81%72.12M
-71.49%98.98M
2.20%347.24M
-47.51%120.57M
Current changes in cash
92.62%-1.15M
-4,260.98%-55.21M
392.07%78.45M
74.85%-62.43M
13.17%-18.75M
-449.65%-15.56M
98.20%-1.27M
82.48%-26.86M
-3,417.61%-248.26M
-118.37%-21.59M
End cash Position
6.05%58.65M
-15.61%59.8M
59.46%115.01M
-63.07%36.55M
-63.07%36.55M
-54.14%55.3M
-42.58%70.86M
-62.81%72.12M
-71.49%98.98M
-71.49%98.98M
Free cash flow
19.61%-40.88M
7.87%-45.97M
34.67%-56.01M
4.13%-228.37M
6.59%-41.89M
8.40%-50.85M
29.71%-49.9M
-28.20%-85.74M
-276.85%-238.21M
-113.72%-44.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.93%-40.55M3.86%-45.5M31.47%-55.46M-5.26%-218.41M-3.53%-40.76M2.08%-49.41M23.36%-47.32M-44.73%-80.92M-194.80%-207.49M-111.53%-39.37M
Net income from continuing operations 3.67%-59.6M26.47%-52.99M5.02%-63.33M6.00%-263.49M-4.93%-62.89M18.04%-61.87M-5.69%-72.06M13.10%-66.68M-319.27%-280.32M-120.38%-59.94M
Operating gains losses -------------2,891.14%-2.21M--0------------101.52%79K--0
Depreciation and amortization -9.40%3.96M-8.66%4.05M0.05%4.18M34.17%17.32M5.07%4.34M23.19%4.37M67.80%4.44M61.25%4.18M34.97%12.91M58.33%4.13M
Other non cash items -45.85%450K-1.42%-715K188.65%617K-125.82%-95K170.37%475K669.44%831K-169.25%-705K-738.55%-696K-91.56%368K-386.02%-675K
Change In working capital 1,074.16%6.07M-139.86%-4.04M72.45%-8.16M-177.89%-10.89M35.61%9.22M-106.24%-623K214.33%10.13M-589.94%-29.61M-65.25%13.98M-83.85%6.8M
-Change in receivables 89.15%-710K-188.77%-6.89M-3.35%9.18M-18.39%3.94M-30.45%3.37M-230.68%-6.54M77.73%-2.39M66.90%9.5M-65.85%4.82M-77.99%4.84M
-Change in prepaid assets -138.46%-981K772.62%3.57M157.37%930K-112.78%-620K-312.01%-1.96M79.52%2.55M-82.19%409K-871.90%-1.62M158.83%4.85M363.25%924K
-Change in payables and accrued expense 82.71%9.23M-167.88%-5.39M53.54%-8.62M95.03%-339K15.14%5.22M7.26%5.05M225.06%7.94M-90.84%-18.55M-124.73%-6.83M-78.03%4.53M
-Change in other current assets 386.29%355K-1.02%6.61M66.74%-4.71M-167.58%-3.2M439.83%4.41M-96.83%-124K224.96%6.68M-837.19%-14.15M200.17%4.73M203.16%816K
-Change in other current liabilities -25.32%-1.95M-11.87%-1.94M-10.38%-4.81M-221.02%-9.16M-365.03%-1.52M-255.96%-1.55M-550.65%-1.74M-154.80%-4.35M-38.80%7.57M-121.52%-326K
-Change in other working capital 2,150.00%123K101.03%8K68.82%-135K-29.79%-1.51M92.63%-294K99.07%-6K---779K---433K-29.59%-1.17M---3.99M
Cash from discontinued investing activities
Operating cash flow 17.93%-40.55M3.86%-45.5M31.47%-55.46M-5.26%-218.41M-3.53%-40.76M2.08%-49.41M23.36%-47.32M-44.73%-80.92M-194.80%-207.49M-111.53%-39.37M
Investing cash flow
Cash flow from continuing investing activities 30.01%50.26M-100.49%-268K-79.11%13.18M1,700.66%190.94M27.24%33.97M-27.12%38.66M5,208.05%55.22M169.65%63.09M97.07%-11.93M112.34%26.7M
Net PPE purchase and sale 77.35%-326K81.61%-474K88.44%-557K67.58%-9.96M79.41%-1.13M71.50%-1.44M72.10%-2.58M56.07%-4.82M63.50%-30.72M62.57%-5.47M
Net investment purchase and sale 26.16%50.58M-99.64%206K-79.77%13.74M968.92%200.9M9.11%35.1M-30.98%40.1M608.62%57.8M185.29%67.91M105.83%18.8M115.95%32.17M
Cash from discontinued investing activities
Investing cash flow 30.01%50.26M-100.49%-268K-79.11%13.18M1,700.66%190.94M27.24%33.97M-27.12%38.66M5,208.05%55.22M169.65%63.09M97.07%-11.93M112.34%26.7M
Financing cash flow
Cash flow from continuing financing activities -125.95%-10.86M-3.09%-9.45M1,435.90%120.73M-21.24%-34.97M-34.10%-11.96M11.30%-4.81M-19.47%-9.16M-32.24%-9.04M-114.77%-28.84M-17.12%-8.92M
Net common stock issuance -95.98%246K--022,543.57%132.01M284.62%6.7M--0446.16%6.12M--0-6.27%583K-99.20%1.74M--0
Proceeds from stock option exercised by employees 332.61%398K-74.37%192K87.69%884K-45.76%1.52M386.05%209K-89.97%92K-50.30%749K39.76%471K-34.50%2.8M-95.63%43K
Net other financing activities -4.42%-11.5M2.76%-9.64M-20.61%-12.17M-29.36%-43.19M-35.79%-12.17M-47.76%-11.01M-8.01%-9.91M-29.49%-10.09M-22.58%-33.39M-4.21%-8.96M
Cash from discontinued financing activities
Financing cash flow -125.95%-10.86M-3.09%-9.45M1,435.90%120.73M-21.24%-34.97M-34.10%-11.96M11.30%-4.81M-19.47%-9.16M-32.24%-9.04M-114.77%-28.84M-17.12%-8.92M
Net cash flow
Beginning cash position -15.61%59.8M59.46%115.01M-63.07%36.55M-71.49%98.98M-54.14%55.3M-42.58%70.86M-62.81%72.12M-71.49%98.98M2.20%347.24M-47.51%120.57M
Current changes in cash 92.62%-1.15M-4,260.98%-55.21M392.07%78.45M74.85%-62.43M13.17%-18.75M-449.65%-15.56M98.20%-1.27M82.48%-26.86M-3,417.61%-248.26M-118.37%-21.59M
End cash Position 6.05%58.65M-15.61%59.8M59.46%115.01M-63.07%36.55M-63.07%36.55M-54.14%55.3M-42.58%70.86M-62.81%72.12M-71.49%98.98M-71.49%98.98M
Free cash flow 19.61%-40.88M7.87%-45.97M34.67%-56.01M4.13%-228.37M6.59%-41.89M8.40%-50.85M29.71%-49.9M-28.20%-85.74M-276.85%-238.21M-113.72%-44.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data